Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fracture Healing | 3 | 2017 | 9 | 0.560 |
Why?
|
| Prostheses and Implants | 7 | 2017 | 41 | 0.560 |
Why?
|
| Osteoporosis | 2 | 2014 | 18 | 0.510 |
Why?
|
| Animals | 13 | 2017 | 748 | 0.440 |
Why?
|
| Femur | 5 | 2014 | 68 | 0.440 |
Why?
|
| Transforming Growth Factor beta | 2 | 2012 | 18 | 0.430 |
Why?
|
| Calcitonin | 1 | 2014 | 5 | 0.430 |
Why?
|
| Fracture Fixation | 1 | 2014 | 5 | 0.430 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 5 | 0.430 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 6 | 0.430 |
Why?
|
| Diphosphonates | 1 | 2014 | 6 | 0.430 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 8 | 0.420 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2012 | 11 | 0.390 |
Why?
|
| Cell Differentiation | 2 | 2010 | 31 | 0.350 |
Why?
|
| Ultrasonic Therapy | 1 | 2010 | 5 | 0.340 |
Why?
|
| Stromal Cells | 1 | 2010 | 9 | 0.340 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 17 | 0.340 |
Why?
|
| Osteogenesis | 1 | 2010 | 37 | 0.330 |
Why?
|
| Bone and Bones | 3 | 2017 | 52 | 0.320 |
Why?
|
| Rats | 8 | 2014 | 159 | 0.290 |
Why?
|
| Osseointegration | 3 | 2014 | 26 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2014 | 95 | 0.260 |
Why?
|
| X-Ray Microtomography | 3 | 2017 | 39 | 0.250 |
Why?
|
| Osteolysis | 2 | 2017 | 21 | 0.240 |
Why?
|
| Male | 6 | 2014 | 1055 | 0.200 |
Why?
|
| Bone Remodeling | 2 | 2014 | 32 | 0.200 |
Why?
|
| Humans | 4 | 2017 | 1907 | 0.160 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 100 | 0.150 |
Why?
|
| Titanium | 2 | 2017 | 32 | 0.140 |
Why?
|
| Low-Level Light Therapy | 1 | 2017 | 1 | 0.140 |
Why?
|
| Calcium Phosphates | 2 | 2005 | 7 | 0.110 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2005 | 7 | 0.110 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 34 | 0.110 |
Why?
|
| Thiophenes | 1 | 2014 | 4 | 0.110 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2014 | 5 | 0.110 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2014 | 8 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 20 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 26 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 2014 | 14 | 0.100 |
Why?
|
| Biomarkers | 1 | 2014 | 56 | 0.100 |
Why?
|
| Materials Testing | 2 | 2012 | 16 | 0.090 |
Why?
|
| Collagen | 1 | 2012 | 22 | 0.090 |
Why?
|
| Models, Animal | 2 | 2017 | 25 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 60 | 0.090 |
Why?
|
| Electron Microscope Tomography | 1 | 2011 | 2 | 0.090 |
Why?
|
| Metals | 1 | 2011 | 5 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 2 | 0.080 |
Why?
|
| Equipment Design | 1 | 2010 | 10 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 9 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 19 | 0.080 |
Why?
|
| Transducers | 1 | 2010 | 3 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2010 | 23 | 0.080 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 9 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2010 | 88 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2010 | 73 | 0.080 |
Why?
|
| Polymers | 1 | 2007 | 5 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2007 | 11 | 0.070 |
Why?
|
| Tissue Engineering | 1 | 2007 | 5 | 0.070 |
Why?
|
| Bone Matrix | 1 | 2007 | 11 | 0.070 |
Why?
|
| Bone Regeneration | 1 | 2007 | 35 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2006 | 6 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2006 | 9 | 0.060 |
Why?
|
| Durapatite | 1 | 2005 | 4 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2005 | 7 | 0.060 |
Why?
|
| Biomimetic Materials | 1 | 2004 | 3 | 0.050 |
Why?
|
| Humerus | 1 | 2014 | 10 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2014 | 15 | 0.030 |
Why?
|
| Tibia | 1 | 2014 | 23 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2014 | 20 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 25 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 60 | 0.030 |
Why?
|
| Periosteum | 1 | 2012 | 3 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2012 | 6 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 12 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 35 | 0.020 |
Why?
|
| Female | 1 | 2012 | 984 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2007 | 5 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2007 | 4 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 7 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2007 | 12 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 5 | 0.020 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2006 | 5 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 14 | 0.020 |
Why?
|
| Dogs | 1 | 2006 | 58 | 0.020 |
Why?
|
| Femoral Fractures | 1 | 2005 | 3 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 143 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 11 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 28 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 69 | 0.010 |
Why?
|